Cutaneous sarcoidosis treated with medium-dose UVA1 [4]

Journal of the American Academy of Dermatology

Volumn 50, Issue 6, 2004, Pages 978-979

  Mahnke, Natalia ^a   Medve Koenigs, Kathrin ^a   Berneburg, Mark ^a   Ruzicka, Thomas ^a   Neumann, Norbert J ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; TACROLIMUS;

AGED; BREAST CANCER; CASE REPORT; DIABETES MELLITUS; FEMALE; HEART FAILURE; HUMAN; HYPERTENSION; LETTER; LUNG FIBROSIS; PRIORITY JOURNAL; RADIATION DOSE; SARCOIDOSIS; SKIN DISEASE; ULTRAVIOLET A RADIATION; ULTRAVIOLET RADIATION;

EID: 2542476138     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2003.09.027     Document Type: Article

References (5)

1. Morita A, Werfel T, Stege H, Ahrens C, Karmann K, Grewe M, et al. Evidence that singlet oxygen-induced human T helper cell apoptosis is the basic mechanism of UVA radiation phototherapy. J Exp Med 1997;186:1763-8.
2. Krutmann J, Stege H, Morita A. UVA1 phototherapy: indications and mode of action. In: Dermatological phototherapy and photodiagnostic methods. New York: Springer; 2001. p. 261-78.
3. Graefe T, Konrad H, Barta U, Elsner P. Successful UVA1 treatment of cutaneous sarcoidosis. Br J Dermatol 2001;145:354-5.
4. Pinton PC, Capezzera R, Zane C, De Panfilis G. Medium-dose UVA1 therapy for pityriasis lichenoides et varioliformis acuta and pityriasis lichenoides chronica. J Am Acad Dermatol 2002;47:410-4.
5. Sterenbroigh HCJM, van der Leun JC. Tumorgenesis by long wave-length UVA source. Photochem Photobiol 1990;51:325-30.